{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:25Z","timestamp":1787908945314,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Start-up Fund for the PhD Talent Program of Children\u2019s Hospital of Nanjing Medical University","award":["BSYC2024015"],"award-info":[{"award-number":["BSYC2024015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05613-y","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:18:05Z","timestamp":1782206285000},"page":"3585-3600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RBM15 promotes hyperglycemia-induced retinal endothelial cell injury by regulating FOXO3 stability via m6A modification"],"prefix":"10.1007","volume":"481","author":[{"given":"Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"5613_CR1","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1111\/dom.16588","volume":"27","author":"Y Pan","year":"2025","unstructured":"Pan Y, Li Y, Cui M, He G, Wang G (2025) Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Diabetes Obes Metab 27:5464\u20135477","journal-title":"Diabetes Obes Metab"},{"key":"5613_CR2","doi-asserted-by":"publisher","first-page":"167758","DOI":"10.1016\/j.bbadis.2025.167758","volume":"1871","author":"H Zhu","year":"2025","unstructured":"Zhu H, Li B, Huang T, Wang B, Li S, Yu K, Cai L, Ye Y, Chen S, Zhu H, Xu J, Lu Q, Ji L (2025) Update in the molecular mechanism and biomarkers of diabetic retinopathy. Biochim Biophys Acta Mol Basis Dis 1871:167758","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5613_CR3","doi-asserted-by":"publisher","first-page":"101799","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C (2020) Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol 37:101799","journal-title":"Redox Biol"},{"key":"5613_CR4","doi-asserted-by":"publisher","first-page":"1037186","DOI":"10.3389\/fnut.2022.1037186","volume":"9","author":"Q Kang","year":"2022","unstructured":"Kang Q, Dai H, Jiang S, Yu L (2022) Advanced glycation end products in diabetic retinopathy and phytochemical therapy. Front Nutr 9:1037186","journal-title":"Front Nutr"},{"key":"5613_CR5","doi-asserted-by":"publisher","first-page":"114496","DOI":"10.1016\/j.yexcr.2025.114496","volume":"447","author":"S He","year":"2025","unstructured":"He S, Gu C, Meng C, Cai C, Lai D, Qiu Q (2025) CircTHADA regulates endothelial cell pyroptosis in diabetic retinopathy through miR-494-3p\/CASP1\/GSDMD-N\/IL-1\u03b2 pathway. Exp Cell Res 447:114496","journal-title":"Exp Cell Res"},{"key":"5613_CR6","doi-asserted-by":"publisher","first-page":"9334","DOI":"10.1038\/s41467-024-53601-x","volume":"15","author":"Y Lei","year":"2024","unstructured":"Lei Y, Liu Q, Chen B, Wu F, Li Y, Dong X, Ma N, Wu Z, Zhu Y, Wang L, Fu Y, Liu Y, Song Y, Du M, Zhang H, Zhu J, Lyons TJ, Wang T, Hu J, Xu H, Chen M, Yan H, Wang X (2024) Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat Commun 15:9334","journal-title":"Nat Commun"},{"key":"5613_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41392-025-02448-9","volume":"10","author":"MA McCann","year":"2025","unstructured":"McCann MA, Baccouche B, Li Y, Roy P, Sheth N, Lim JI, Mieler WF, Chau FY, Ulanski LJ, Chan RVP, Munro M, Hyde RA, Berek C, Ong A, De S, Siedlecki B, Chee RI, Leiderman YI (2025) Heiferman MJ and Kazlauskas A. Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction. Signal Transduct Target Ther 10:350","journal-title":"Signal Transduct Target Ther"},{"key":"5613_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","volume":"54","author":"A Arrigo","year":"2022","unstructured":"Arrigo A, Aragona E, Bandello F (2022) VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy. Ann Med 54:1089\u20131111","journal-title":"Ann Med"},{"key":"5613_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, Gardiner TA, Lyons TJ, Hammes HP (2016) Sim\u00f3 R and Lois N. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156\u2013186","journal-title":"Prog Retin Eye Res"},{"key":"5613_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","volume":"18","author":"CM Andreoli","year":"2007","unstructured":"Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18:502\u2013508","journal-title":"Curr Opin Ophthalmol"},{"key":"5613_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","volume":"22","author":"G Uludag","year":"2022","unstructured":"Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Trong Tuong Than N, Doan HL, Akhavanrezayat A, Halim MS, Do DV, Nguyen QD (2022) Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? Expert Opin Biol Ther 22:1275\u20131291","journal-title":"Expert Opin Biol Ther"},{"key":"5613_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s11892-022-01491-y","volume":"22","author":"JA Zehden","year":"2022","unstructured":"Zehden JA, Mortensen XM, Reddy A, Zhang AY (2022) Systemic and Ocular Adverse Events with Intravitreal Anti-VEGF Therapy Used in the Treatment of Diabetic Retinopathy: a Review. Curr Diab Rep 22:525\u2013536","journal-title":"Curr Diab Rep"},{"key":"5613_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11739-019-02253-7","volume":"15","author":"M Porta","year":"2020","unstructured":"Porta M, Striglia E (2020) Intravitreal anti-VEGF agents and cardiovascular risk. Intern Emerg Med 15:199\u2013210","journal-title":"Intern Emerg Med"},{"key":"5613_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling C, R\u00f6nn T (2019) Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab 29:1028\u20131044","journal-title":"Cell Metab"},{"key":"5613_CR15","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D, Qiao Y, Tang C (2020) Role of m6A RNA methylation in cardiovascular disease (Review). Int J Mol Med 46:1958\u20131972","journal-title":"Int J Mol Med"},{"key":"5613_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H (2022) The role of m6A RNA methylation in cancer metabolism. Mol Cancer 21:14","journal-title":"Mol Cancer"},{"key":"5613_CR17","doi-asserted-by":"publisher","first-page":"113115","DOI":"10.1016\/j.yexcr.2022.113115","volume":"415","author":"W Wu","year":"2022","unstructured":"Wu W, Zhang F, Zhao J, He P, Li Y (2022) The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer. Exp Cell Res 415:113115","journal-title":"Exp Cell Res"},{"key":"5613_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","volume":"14","author":"W Huang","year":"2021","unstructured":"Huang W, Chen TQ, Fang K, Zeng ZC, Ye H, Chen YQ (2021) N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. J Hematol Oncol 14:117","journal-title":"J Hematol Oncol"},{"key":"5613_CR19","doi-asserted-by":"publisher","first-page":"1187514","DOI":"10.3389\/fcvm.2023.1187514","volume":"10","author":"X Zhang","year":"2023","unstructured":"Zhang X, Cai H, Xu H, Dong S, Ma H (2023) Critical roles of m(6)A methylation in cardiovascular diseases. Front Cardiovasc Med 10:1187514","journal-title":"Front Cardiovasc Med"},{"key":"5613_CR20","doi-asserted-by":"publisher","first-page":"1102147","DOI":"10.3389\/fnmol.2023.1102147","volume":"16","author":"Y Fan","year":"2023","unstructured":"Fan Y, Lv X, Chen Z, Peng Y, Zhang M (2023) m6A methylation: Critical roles in aging and neurological diseases. Front Mol Neurosci 16:1102147","journal-title":"Front Mol Neurosci"},{"key":"5613_CR21","doi-asserted-by":"publisher","first-page":"114291","DOI":"10.1016\/j.yexcr.2024.114291","volume":"443","author":"Y Yu","year":"2024","unstructured":"Yu Y, Nie H, Qin X, Chen X, Li X, Yao J (2024) METTL14-mediated m6A methylation regulates pathological retinal neovascularization by targeting autophagy. Exp Cell Res 443:114291","journal-title":"Exp Cell Res"},{"key":"5613_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Wang Y, Wang JN, Zhang YC, Zhang YR, Sun RX, Qin B, Dai YX, Zhu HJ, Zhao JX, Zhang WW, Ji JD, Yuan ST, Shen QD, Liu QH (2024) Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med 16:294\u2013318","journal-title":"EMBO Mol Med"},{"key":"5613_CR23","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1111\/dme.70033","volume":"42","author":"Q Liao","year":"2025","unstructured":"Liao Q, Li Y, Cui M, Liu M (2025) m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A-YTHDF1-ACSL4 axis. Diabet Med 42:e70033","journal-title":"Diabet Med"},{"key":"5613_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"5613_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-025-06205-y","volume":"23","author":"S Hu","year":"2025","unstructured":"Hu S, Zhan N, Li J, Wang L, Liu Y, Jin K, Wang Y, Zhang J, Chen Y, Bai Y, Wang Y, Qi L, Liu S (2025) RBM15 recruits myeloid-derived suppressor cells via the m6A-IGF2BP3\/CBR3-AS1\/miR-409-3p\/CXCL1 axis, facilitating radioresistance in non-small-cell lung cancer. J Transl Med 23:191","journal-title":"J Transl Med"},{"key":"5613_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jacbts.2024.01.017","volume":"9","author":"H Cheng","year":"2024","unstructured":"Cheng H, Wu J, Li L, Song X, Xue J, Shi Y, Zou Y, Ma J, Ge J (2024) RBM15 Protects From Myocardial Infarction by Stabilizing NAE1. JACC Basic Transl Sci 9:631\u2013648","journal-title":"JACC Basic Transl Sci"},{"key":"5613_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/02713683.2024.2362855","volume":"49","author":"P Xie","year":"2024","unstructured":"Xie P, He J, Ou Y (2024) RBM15 Promotes High Glucose-Induced Lens Epithelial Cell Injury by Inducing PRNP N6-Methyladenine Modification During Diabetic Cataract. Curr Eye Res 49:1145\u20131153","journal-title":"Curr Eye Res"},{"key":"5613_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/annrheumdis-2021-221091","volume":"81","author":"X Chen","year":"2022","unstructured":"Chen X, Gong W, Shao X, Shi T, Zhang L, Dong J, Shi Y, Shen S, Qin J, Jiang Q, Guo B (2022) METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann Rheum Dis 81:87\u201399","journal-title":"Ann Rheum Dis"},{"key":"5613_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","volume":"16","author":"X Wang","year":"2020","unstructured":"Wang X, Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, Liu Q, Shi H, Wang F, Wang Y (2020) m(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7. Autophagy 16:1221\u20131235","journal-title":"Autophagy"},{"key":"5613_CR30","doi-asserted-by":"publisher","first-page":"e2412379","DOI":"10.1002\/advs.202412379","volume":"12","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Zhang C, Liu R, Zhu Z, Long D, Wen X, Yang Z, Jiang D, Mao G, Liao W, Zhang Z (2025) M(6)A Demethyltransferase FTO Attenuates Meniscus Degeneration and Osteoarthritis via Orchestrating Autophagy and Energetic Metabolism. Adv Sci (Weinh) 12:e2412379","journal-title":"Adv Sci (Weinh)"},{"key":"5613_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","volume":"20","author":"G Calissi","year":"2021","unstructured":"Calissi G, Lam EW, Link W (2021) Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov 20:21\u201338","journal-title":"Nat Rev Drug Discov"},{"key":"5613_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2024","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BMT (2024) FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol 25:46\u201364","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5613_CR33","doi-asserted-by":"publisher","first-page":"122769","DOI":"10.1016\/j.lfs.2024.122769","volume":"350","author":"XD Hao","year":"2024","unstructured":"Hao XD, Liu JX, Zhang JS (2024) Longevity factor FOXO3a: A potential therapeutic target for age-related ocular diseases. Life Sci 350:122769","journal-title":"Life Sci"},{"key":"5613_CR34","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/s41467-022-32963-0","volume":"13","author":"W Hao","year":"2022","unstructured":"Hao W, Dian M, Zhou Y, Zhong Q, Pang W, Li Z, Zhao Y, Ma J, Lin X, Luo R, Li Y, Jia J, Shen H, Huang S, Dai G, Wang J, Sun Y, Xiao D (2022) Autophagy induction promoted by m(6)A reader YTHDF3 through translation upregulation of FOXO3 mRNA. Nat Commun 13:5845","journal-title":"Nat Commun"},{"key":"5613_CR35","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.preteyeres.2024.101271","volume":"101","author":"A Serikbaeva","year":"2024","unstructured":"Serikbaeva A, Li Y, Ma S, Yi D, Kazlauskas A (2024) Resilience to diabetic retinopathy. Prog Retin Eye Res 101:101271","journal-title":"Prog Retin Eye Res"},{"key":"5613_CR36","doi-asserted-by":"crossref","unstructured":"Duh EJ, Sun JK, Stitt AW (2017) Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI insight 14:e93751.","DOI":"10.1172\/jci.insight.93751"},{"key":"5613_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41388-024-03220-z","volume":"44","author":"H Li","year":"2025","unstructured":"Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, Mu Y, Shen W, Tong J, Chen H, Hu Z, Zhang J, Qiu K, Chen W, Cheng X, Xu G (2025) RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene 44:307\u2013321","journal-title":"Oncogene"},{"key":"5613_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/90054","volume":"28","author":"Z Ma","year":"2001","unstructured":"Ma Z, Morris SW, Valentine V, Li M, Herbrick JA, Cui X, Bouman D, Li Y, Mehta PK, Nizetic D, Kaneko Y, Chan GC, Chan LC, Squire J, Scherer SW, Hitzler JK (2001) Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 28:220\u2013221","journal-title":"Nat Genet"},{"key":"5613_CR39","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1182\/blood.2024027712","volume":"146","author":"MY Mayday","year":"2025","unstructured":"Mayday MY, Biancon G, Wei M, Ramirez C, Moratti I, Pintado-Urbanc AP, Espinosa JA, Chen M, Wang L, Simon MD, Ofir-Rosenfeld Y, Rausch O, Tebaldi T, Halene S, Krause DS (2025) RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and Wnt pathway activation. Blood 146:1096\u20131109","journal-title":"Blood"},{"key":"5613_CR40","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/tox.23917","volume":"38","author":"Y Qin","year":"2023","unstructured":"Qin Y, Wu S, Zhang F, Zhou X, You C, Tan F (2023) N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway. Environ Toxicol 38:2772\u20132782","journal-title":"Environ Toxicol"},{"key":"5613_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","volume":"29","author":"J Fang","year":"2023","unstructured":"Fang J, Wu X, He J, Zhang H, Chen X, Zhang H, Novakovic B, Qi H, Yu X (2023) RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Mol Med 29:23","journal-title":"Mol Med"},{"key":"5613_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/1753-0407.13373","volume":"15","author":"X Yang","year":"2023","unstructured":"Yang X, Huang Z, Xu M, Chen Y, Cao M, Yi G, Fu M (2023) Autophagy in the retinal neurovascular unit: New perspectives into diabetic retinopathy. J Diabetes 15:382\u2013396","journal-title":"J Diabetes"},{"key":"5613_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41418-019-0287-8","volume":"26","author":"MB Schaaf","year":"2019","unstructured":"Schaaf MB, Houbaert D, Mece O, Agostinis P (2019) Autophagy in endothelial cells and tumor angiogenesis. Cell Death Differ 26:665\u2013679","journal-title":"Cell Death Differ"},{"key":"5613_CR44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147:728\u2013741","journal-title":"Cell"},{"key":"5613_CR45","doi-asserted-by":"publisher","first-page":"695267","DOI":"10.3389\/fphar.2021.695267","volume":"12","author":"A Adornetto","year":"2021","unstructured":"Adornetto A, Gesualdo C, Lagan\u00e0 ML, Trotta MC, Rossi S, Russo R (2021) Autophagy: A Novel Pharmacological Target in Diabetic Retinopathy. Front Pharmacol 12:695267","journal-title":"Front Pharmacol"},{"key":"5613_CR46","doi-asserted-by":"crossref","unstructured":"Fresia D, Cannizzaro E, Borgo A, Schwab M, Roduit R (2025) Autophagy Impairment in Retinal Ganglion Cells Following Hypoglycemia in Mice. Cells. ;14","DOI":"10.3390\/cells14221774"},{"key":"5613_CR47","doi-asserted-by":"crossref","unstructured":"Chen Y, Jin Y (2025) Ginsenoside Rg1 alleviates HG-induced autophagy of retinal microvascular endothelial cells by activating ACE2\/Ang1-7\/Mas in vitro.Sci Rep 15:45315.","DOI":"10.1038\/s41598-025-29344-0"},{"key":"5613_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbrc.2020.07.134","volume":"531","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu X, Zhu L, Li W, Li Z, Lu X, Liu J, Hua W, Zhou Y, Gu Y, Zhu M (2020) PG545 alleviates diabetic retinopathy by promoting retinal M\u00fcller cell autophagy to inhibit the inflammatory response. Biochem Biophys Res Commun 531:452\u2013458","journal-title":"Biochem Biophys Res Commun"},{"key":"5613_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00018-023-04755-2","volume":"80","author":"M Omorou","year":"2023","unstructured":"Omorou M, Huang Y, Gao M, Mu C, Xu W, Han Y, Xu H (2023) The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury. Cell Mol Life Sci 80:102","journal-title":"Cell Mol Life Sci"},{"key":"5613_CR50","doi-asserted-by":"publisher","first-page":"121877","DOI":"10.1016\/j.lfs.2023.121877","volume":"328","author":"G Cao","year":"2023","unstructured":"Cao G, Lin M, Gu W, Su Z, Duan Y, Song W, Liu H, Zhang F (2023) The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts. Life Sci 328:121877","journal-title":"Life Sci"},{"key":"5613_CR51","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","volume":"19","author":"J Niu","year":"2023","unstructured":"Niu J, Yan T, Guo W, Wang W, Ren T, Huang Y, Zhao Z, Yu Y, Chen C, Huang Q, Lou J, Guo L (2023) The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy 19:1693\u20131710","journal-title":"Autophagy"},{"key":"5613_CR52","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/15548627.2018.1556946","volume":"15","author":"JW Lee","year":"2019","unstructured":"Lee JW, Nam H, Kim LE, Jeon Y, Min H, Ha S, Lee Y, Kim SY, Lee SJ, Kim EK, Yu SW (2019) TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia. Autophagy 15:753\u2013770","journal-title":"Autophagy"},{"key":"5613_CR53","doi-asserted-by":"publisher","first-page":"156161","DOI":"10.1016\/j.phymed.2024.156161","volume":"135","author":"YY Lu","year":"2024","unstructured":"Lu YY, Fang YY, Wang SS, Guo J, Song JL, Zhu L, Lin ZK, Wang R, Zhang SY, Qiu WS, Qi WW (2024) Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy. Phytomedicine 135:156161","journal-title":"Phytomedicine"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05613-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:55Z","timestamp":1787908495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5613"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05613-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}